Oxygen Therapy Equipment Market Key Players, Share, Trend, Segmentation and Forecast

A number of factors, such as increasing prevalence of respiratory disorders, rapid growth in the geriatric population, high prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements are expected to drive the growth of this market.

According MarketsandMarkets™ Research – The report “Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) – Global Forecast to”, is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7%

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=118828572

Oxygen source equipment is expected to dominate the market.

On the basis of products, segmented into oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is expected to dominate the global oxygen therapy equipment market in 2017. The increasing incidence of respiratory disorders and technological advancements to develop smaller, quieter and more effective equipment are key drivers increasing the demand for oxygen source equipment.

Stationary oxygen therapy devices are estimated to command the largest market share.

The oxygen therapy equipment market is segmented by portability into stationary devices and portable devices. The stationary devices segment is expected to account for the largest share of the market, by portability. Severe complications in patients suffering from respiratory disorders and the increasing proportion of geriatric population across the globe are major drivers for the growth of this segment.

Geographical View in-detailed:

The global oxygen therapy equipment market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, Japan, and India. Increasing investment in healthcare, increase in healthcare expenditure, growth in disposable incomes, and an increase in healthcare insurance coverage are some factors propelling market growth in the APAC region.

The availability of low-cost substitutes by local manufacturers, rigorous regulatory guidelines causing delays in product approvals, and Medicare reimbursement rate cuts for home oxygen therapy in the U.S. are expected to restrain the market growth to a certain extent.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118828572

Global Key Leaders:

Key players in the oxygen therapy equipment market include Philips Healthcare (Netherlands), Linde Healthcare (Germany), Chart Industries, Inc. (U.S.), Invacare Corporation (U.S.), Becton, Dickinson and Company (U.S.), Smiths Medical (U.S.), Drägerwerk AG & Co. KGaA (Germany), Teleflex Incorporated (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Taiyo Nippon Sanso Corporation (Japan), Inogen, Inc. (U.S.), Heinen + Löwenstein GmbH & Co. KG (Germany)

Philips Healthcare (Netherlands) dominated the oxygen therapy equipment market. The company provides oxygen therapy devices through its Sleep and Respiratory Care business area. Philips Healthcare derives a majority of its revenue from the North American market. The company focuses on providing sophisticated products like oxygen concentrators, liquid oxygen devices, and oxygen cylinders. It is also looking at broadening its product offerings in the market via product launches. In 2016, Philips Healthcare, a market leader providing oxygen therapy equipment, developed Respironics EverGo, a portable oxygen concentrator which does not require refill or tank replacement. This enhances patient comfort as the patient does not have to depend on external parties for consumables.

Global Active Implantable Medical Devices Market Size, and Growth Projection

The Active Implantable Medical Devices Market is expected to witness significant growth in the coming years. The growing aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries are some of the factors driving the growth of this market.

According MarketsandMarkets™ Research – The report “Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) – Global Forecast”, witnessed healthy growth during the last decade and is expected to grow at a CAGR of 7.8%, to reach USD 26.75 Billion.

Market Opportunities;

– Emerging Markets Offer Significant Growth Opportunities
– Development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=102063992

On the basis of product, the market is segmented into implantable cardioverter defibrillators, implantable cardiac pacemakers, implantable heart monitors/insertable loop recorders, ventricular assist devices, neurostimulators, and implantable hearing devices. The implantable cardioverter defibrillators segment accounted for the largest share of the implantable and life-sustaining devices market in 2016, owing to the increasing incidence of cardiovascular diseases, development of technologically advanced devices, and increasing demand for these devices in emerging countries.

The active implantable medical devices market is highly consolidated in nature where the prominent players are accounting for the major share. To expand their geographic presence and garner higher shares in this market, major players are continuously focusing on product launches; mergers and acquisitions; agreements, partnerships, and collaborations; and expansions. The implantable cardiovascular devices market was dominated by three major players in 2015, together accounted for a share of around 85%. Similarly, the implantable neurostimulators devices market was led by three major players in 2015, together accounted for a share of around 95%.

Geographical View in-detailed:

North America is the largest regional segment for the active implantable medical devices market. The large share of this regional segment can be attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increasing development of innovative and technologically advanced products, and increasing healthcare expenditure in the region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to the growth in geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, growing demand for advanced technologies to develop advanced products, and less stringent regulations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102063992

Global Key Leaders: Some of the prominent players in the active implantable medical devices market include Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and LivaNova PLC (U.K.). Whereas, Cochlear Limited (Australia), MED-EL (Austria), Sonova Holding AG (Switzerland), William Demant Holding A/S (Denmark), and Nurotron Biotechnology Co., Ltd. (China) are the key players in the implantable hearing devices market.

Synthetic Stem Cells Market Analysis, Geographical Segmentation, Drivers, Challenges, Trends Forecasts Report

The study involved four major activities in estimating the current market size for synthetic stem cells. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Secondary Research:

In the secondary research process, various secondary sources such as Hoovers, Bloomberg Business Week, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for this technical, market-oriented, and commercial study of the synthetic stem cells industry. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; gold standard & silver standard websites; food safety organizations; regulatory bodies; trade directories; and databases. Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, market classification, and segmentation, according to the industry trends to the bottom-most level and regional markets.

According to the new market research report “Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) – Global Forecast to 2028″ published by MarketsandMarkets™, the artificial stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435

Geographically; North America is estimated to account for the largest share of the market in 2023. North America is the pioneer of synthetic stem cell technology. Also, North America leads in the R&D of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018. This is further backed by the high rate of adoption of advanced therapies in the US (more than 600 stem cell therapy clinics in the US in 2016).

The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).

Market Size Estimation;

The top-down approach was used to estimate and validate the total size of the synthetic stem cells market. The approach was also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

– Synthetic stem cells that could be used as therapy were identified through secondary research, and their market shares in the respective segments were determined through primary and secondary research.

– The procedure included extensive interviews with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights.

– All percentage shares, splits, and breakdowns were determined using secondary sources and are verified through primary sources.

– All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4959435

The cardiovascular diseases segment accounted for the largest share during the forecast period.

The major applications of synthetic stem cells include cardiovascular diseases, neurological disorders, and other diseases that require regenerative therapy. Cardiovascular diseases have high prevalence across the globe. Currently, synthetic mesenchymal cells have been developed only for cardiac tissue and have been tested in mice models. The research on cardiac synthetic stem cells is expected to enter the clinical phase in the coming 2-3 years, and the first commercial product would be cardiac synthetic stem cells in the next five years.

Veterinary X-ray Market Size, Share, Outlook, Industry Analysis Report 2018

The study involved four major activities to estimate the current market size for veterinary X-ray products. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, trade directories, and databases such as D&B Hoovers and Bloomberg Businessweek were referred to identify and collect information for this study.

According to the new market research report “Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) – Forecast” published by MarketsandMarkets™, is projected to reach USD 872 million by 2023 from USD 640 million in 2018, at a CAGR of 6.4%.

Recent Developments:

– In 2018, Heska Corporation (US) formed a partnership with Pathway Vet Alliance (US). Under the terms of this agreement, Pathway plans to align its internal diagnostic portfolio with Heska, which can provide in-house operational services like point-of-care blood diagnostics, digital imaging, and allergy testing.

– In 2018, Carestream Health signed a service partnership agreement with Med Imaging Healthcare, a Diagnostic Imaging equipment maintenance company. The partnership was aimed at providing wider maintenance coverage and support for Carestream customers across Scotland.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=126397675

Geographically; North America accounted for the largest share of the veterinary X-ray market in 2017, followed by Europe and the Asia Pacific. Rising number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the animal x-ray market in North America.

The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126397675

Market Segmentation in Detailed:

“Computed Radiography Systems Accounted for the Largest Market Share”

On the basis of technology, the veterinary X-ray market is segmented into direct radiography (DR), computed radiography (CR), and film-based radiography systems. The computed radiography systems segment accounted for the largest share of the animal X-ray market in 2017. Benefits offered by CR systems over traditional X-ray systems, resulting in a large-scale replacement of traditional film X-ray systems, is the major factor responsible for the large share of this segment.

“Small Companion Animals Segment Held the Largest Share of the Veterinary X-ray Market”

Based on the type of animal, the X-ray market is segmented into small companion animals and large animals. The small companion animals segment accounted for the largest share of the animal X-ray market in 2017. The large share of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, growing demand for pet insurance, and technological advancements in imaging modalities for small companion animals.

Microservices in Healthcare Market - Global Industry Analysis,Share, Trends, Status and Future Forecast

The benefits of microservice architecture, such as their ability to increase overall efficiency and project delivery speed, are the primary factor driving the market growth. However, concerns regarding security and regulatory compliance and the complexity of architecture are expected to hinder the growth of this market.

According to the new market research report “Microservices in Healthcare Market by Component (Platform, Services (Consulting, Integration, Training, Support, Maintenance)), Delivery (Cloud, Hybrid, Private, On-premise), End User (Health care Provider, Payer, Life Science) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 343.3 million by 2023 from the estimated USD 103.1 million in 2017, at a CAGR of 21.3%.

The Objectives of this study are as follows:

– To define, describe, and forecast the global microservices in healthcare market by deployment model, component, end user, and region

– To provide detailed information about the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

– To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

– To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=119908608

Geographically; North America is estimated to command the largest share of the market. The large share of North America in the global microservices in healthcare market can be attributed to the growing focus on improving the overall efficiency of healthcare organizations and greater product and service availability in the region.

The microservices in healthcare market is marked by the presence of several big and small players. Prominent players in this market include AWS (US), CA Technologies (US), Microsoft (US), Salesforce (US), Pivotal Software (US), Infosys (India), IBM (US), NGINX (US), Oracle Corporation (US), and Syntel (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119908608

Market Segmentation in Detailed:

The platform segment is expected to dominate the microservices in healthcare market in 2018.

Based on component, segmented into platforms and services. The services segment is further segmented into consulting services, integration services, and training, support, and maintenance services. The platforms segment is expected to account for the larger share of the microservices in healthcare market in 2018. This is attributed to the increasing need for cloud microservice architecture for scaling functions at a very granular level for efficient system optimization and organization. Cloud platform microservice architecture also brings a new level of scalability to enterprise applications.

The healthcare providers segment is expected to dominate the market in 2018.

Based on end user, the microservices in healthcare market is segmented into healthcare payers, healthcare providers, life science organizations, and clinical laboratories. The healthcare providers segment is expected to account for the largest share of the overall market in 2018. Government initiatives that help providers gain incentives on the adoption of EHRs and the implementation of integration and connectivity solutions are driving the adoption of microservices architecture solutions among healthcare providers.

Urgent Care Apps Market Size, Opportunities for Revenue Growth, and Future Forecast

The growth of Urgent Care Apps Market is influenced by a number of factors, such as the increasing penetration of smartphones, growing penetration of 3G and 4G networks, rising focus on patient-centric healthcare delivery, and the benefits offered by urgent care apps. However, the wide usage of consumer instant messaging apps, poor internet connectivity in several countries, and the high volume of miscategorized apps on Android and Apple stores are the major factors that are expected to restrain the growth of this market during the forecast period.

According to the new market research report “Urgent Care Apps Market by Type (Emergency Care Triage Apps, In-hospital Communication Apps, Post-hospital Apps (Nurse Communication Apps, Rehab Apps, Medication Management Apps)), Clinical Area (Stroke, Trauma, STEMI) – Global Forecast” published by MarketsandMarkets™, is expected to reach USD 2,515.1 million, at a CAGR of 41.3% during the forecast period.

Objectives of the Study:

• To define, describe, segment, and forecast the global urgent care apps industry by type, clinical area, and region.
• To forecast the size of the urgent care apps market in North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.
• To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=45792223

Geographically; North America is expected to hold the largest share of the urgent care apps market in 2018, followed by Europe. The growth of the North American apps market is driven by the implementation of regulations in the region regarding the safety of patient data and improving quality of care, increasing penetration of 4G networks, rising need to reduce the escalating healthcare costs, and the rising focus on patient-centric healthcare delivery.

Some of the prominent players in urgent care apps market are Allm (Japan), Pulsara (US), Vocera Communications (US), PatientSafe Solutions (US), Voalte (US), Twiage (US), TigerConnect (US), Imprivata (US), Siilo (Netherlands), Forward Health (UK), Hospify (UK), Argusoft (US), Alayacare (US), Pivot Design Group (Canada), Medisafe (US), Smartpatient (Germany), and Johnson & Johnson (US).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45792223

Market Segmentation in Detailed:

The post-hospital apps segment held the largest share of the market in 2018.

On the basis of type, the urgent care apps market is segmented into pre-hospital emergency care & triaging apps, in-hospital communication & collaboration apps, and post-hospital apps. In 2017, the post-hospital apps segment accounted for the largest share of the apps market. With growing concerns about medication noncompliance and medication dosage errors, the adoption of medication management apps is on the rise. Better connectivity and networks have enhanced the outcome of such apps, which is further boosting the adoption of these apps by patients and healthcare professionals.

In 2018, the trauma segment is expected to account for the largest share of the market.

Based on clinical area, the global urgent care apps market is broadly segmented into trauma, stroke, cardiac conditions, and other clinical areas. In 2018, the trauma segment is slated to account for the largest share of the market. The increasing number of road accident across the globe is driving the growth of this segment. As the awareness to address trauma is increasing due to continuous efforts by health organizations, such as WHO, the adoption of apps to manage trauma and casualty among paramedics and emergency centers is also growing.

Ureteroscopy Market 2021 - by Global In-depth Analysis, Regional Outlook, Latest Trend and Forecast

The high incidence of urolithiasis across the globe is a major factor driving the growth of Ureteroscopy Market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible ureteroscopy market in the coming years.

According to the new market research report “Flexible and Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) – Global Forecast” published by MarketsandMarkets™, the global semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million, at a CAGR of 5.4%

The Objectives of this Study are as follows:

• To define, describe, and forecast the flexible & semi-rigid ureteroscopy market by product type, application, end user, and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795

Geographically; the flexible and semi-rigid ureteroscopy market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region. Asia is expected to grow at the highest CAGR in the flexible ureteroscopy market during the forecast period. Growth in this region is mainly due to the large patient population.

Some of the major players operating in ureteroscopy market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795

Market Segmentation in Detailed:

Flexible ureteroscopes are expected to account for the largest share of the market in 2018

By type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share in 2018. The growing incidence of urolithiasis, rising prevalence rate of kidney cancers, and technological advancements in flexible ureteroscopes are the primary factors driving the growth of the ureteroscopy market. The flexible ureteroscopes market is further segmented into fiberoptic and digital ureteroscopes. The digital ureteroscopes segment is expected to account for the larger market share in 2018 owing to the higher efficacy and better image output of these devices.

Hospitals are expected to dominate the flexible and semi-rigid ureteroscopy end-user market in 2018

By end user, the flexible and semi-rigid ureteroscopy market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment is expected to account for the largest share of the flexible ureteroscopy market. This large share can be attributed to the high number of surgeries performed in hospitals.

Medical Vacuum System Market Research Report 2019-2024 By Key players and Growth Rate

The Factors such technological advancements in vacuum systems, stringent regulatory frameworks mandating the use of vacuum systems, the increasing number of target surgical procedures across major markets, and the rising number of Diagnostic Imaging procedures are driving the growth of the global medical vacuum systems market.

According to the new market research report “Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) – Global Forecast to 2024″ published by MarketsandMarkets™, is estimated to grow at a CAGR of 6.3% to reach USD 1.6 billion.

Recent Developments:

-> In November 2018, Busch LLC (Germany) and Pfeiffer Vacuum Technology AG (Germany) entered into a strategic cooperation agreement in order to enhance segments such as sales & services, R&D developments, and improve the vacuum product line.

-> In October 2018, ConvaTec (UK) received the US FDA 510(k) Clearance for its Avelle Negative Pressure Wound Therapy System.

-> In March 2018, Atlas Copco AB (Sweden) acquired Walker Filtration for USD 38.68 million for enhancing its vacuum business

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=150008017

Geographically; North America accounted for the largest share of the medical vacuum systems market in 2018. The dominant position of this region in the medical vacuum systems industry is due to technology advancements; cleanroom mandates, manufacturing guidelines, and surgical protocols; increased number of target medical procedures and trauma cases; a growing number of end users; the rising number of diagnostic imaging procedures; and rising expenditure healthcare infrastructure in the country.

Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are some major players in the global medical vacuum systems market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150008017

Market Segmentation in Detailed:

The standalone vacuum systems segment is expected to account for the largest share of the medical vacuum systems market.

On the basis of product type, segmented into standalone vacuum systems, centralized vacuum systems, portable vacuum systems, and accessories. The standalone vacuum systems segment accounted for the largest share of the medical vacuum systems market in 2018. The large share of this segment can be attributed to the large end-user base for compact/standalone products, their technical advantages, and significant adoption among dental clinics and research labs.

The therapeutic applications segment is expected to register the highest growth rate in the vacuum systems market.

On the basis of application, the medical vacuum systems market is segmented into pharma-biotech manufacturing, therapeutic applications, diagnostic applications, and research applications. Therapeutic applications are further segmented into dental, wound care, anesthesiology, and gynecology applications. The therapeutic applications segment is expected to register the highest growth rate due to the rising incidence of dental caries and other periodontal diseases, increasing use of NPWT for diabetic ulcers, and the increasing number of target medical procedures across major markets.